Harvard University’s endowment has participated in a funding round for the robo-advisory platform.
Athenex will pay $70m upfront and up to $115m in milestone payments to acquire Kuur Therapeutics, providing exits to Baylor College and IP Group.
NeoGenomics has exercised its option to buy Inivata, a precision cancer diagnostics company that was formed to exploit Cambridge and CRUK research seven years ago.
Oxford Nanopore, the UK-based DNA sequencing technology spinout of University of Oxford, pocketed £195m ($270m) in equity financing today from investors including commercialisation firm IP Group. Imaging technology producer Nikon, Temasek, Wellington Management and M&G Investment took part in the round, providing $174m, while unnamed, existing backers also contributed capital. IP Group committed £26m, its […]
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Vaccitech, which developed the technology underlying Oxford’s covid vaccine, has priced its shares and will raise more than $110m in its IPO.
Novo Seeds co-led a $61.7m round for the oncology therapy developer to help commercialise research originating at University of Copenhagen and Rigshospitalet.
Stanford University returned for the cryptocurrency exchange infrastructure developer's series B round.
Less than two months after closing a $100m series C round, the Durham spinout has raised $225m in a series D led by SoftBank Vision Fund 2.
Yale’s immunological and inflammatory disease therapy developer has filed for an offering with an $86.3m placeholder target.